Trade Names: Deca, Deca-Durabolin, Nandrolone Phenylpropionate

Chemical Names: Nandrolone

Routes: Intramuscular Injection

Half-life: NPP 3 days / Decanoate 10-15 Days

Nandrolone Phenylpropionate is, so to speak, the younger brother of the well-known nandrolone decanoate, from which it differs mainly in its shorter duration, which implies the need for more frequent application. It gets into the blood shortly after application and is active for several days. The available information suggests that anabolic consumers wishing to achieve the desired results with this agent should therefore repeat the application every 2-3 days. Its effect greatly increases protein synthesis, which is sought after both in the volume period and in the preparation for competition, because it causes much less water retention in the body compared to nandrolone decanoate. In addition, the increments obtained by nandrolone phenylpropionate are better and more durable than with nandrolone decanoate. Reportedly its side effects are slightly weaker. Nandrolone has been shown to interact with both the androgen and progesterone receptors as well as increase IGF-1 levels in the body. This drug is also highly suppressive when supraphysiologic doses are used; some people say a single shot of Deca can completely supress natural testosterone production. It is also recommended to use an Aromatase Inhibitor compound like Anastrozolone (Arimidex) and even included prolactin lowering drugs like Dostinex or Parlodel (Bromocriptine) to your cycles or during PCT.

Dosing is in the range of 50-100 mg per dose, or 150-300 mg per week. Naturally, experienced anabolic consumers rarely abuse anabolic-androgenic steroids alone, but combine them together. Published information suggests that the most common doping dose is supplemented with either stanozolol, testosterone propionate, methandienone, oxandrolone, or even oxymetholone and testosterone undecanoate.

The therapeutic application is used for exhaustive diseases with a negative nitrogen balance, osteoporosis, including that resulting from long-term corticosteroid therapy, convalescence after severe infections, surgeries and burns, metastatic breast tumors, cytostatic therapy and radiotherapy, etc.